Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.